Processa Pharmaceuticals, Inc.
(NASDAQ : PCSA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Producer Manufacturing » Industrial Machinery
symbolcompany%chnglast%shortavg$volume
AMATApplied Materials, Inc. -0.12%132.891.5%$1069.22m
ASMLASML Holding NV 0.17%681.780.7%$487.24m
CARRCarrier Global Corp. -0.42%46.310.0%$244.57m
PHParker-Hannifin Corp. -0.02%287.992.2%$234.00m
ITWIllinois Tool Works, Inc. 0.42%224.062.3%$210.57m
DDD3D Systems Corp. 28.55%37.1319.9%$161.52m
NNDMNano Dimension Ltd. 3.44%7.850.0%$111.23m
IRIngersoll Rand, Inc. -0.70%46.590.9%$96.75m
XYLXylem, Inc. 0.22%116.592.8%$90.62m
MIDDThe Middleby Corp. 0.30%166.315.6%$90.39m
DOVDover Corp. 0.69%147.311.3%$87.17m
IEXIDEX Corp. 1.03%219.342.1%$63.43m
WBTWelbilt, Inc. -1.24%23.865.2%$62.17m
CFXColfax Corp. 1.03%45.142.1%$61.87m
NDSNNordson Corp. -0.37%218.742.7%$54.71m

Company Profile

Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its lead product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on March 29, 2011 and is headquartered in Hanover, MD.